A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The purpose is to evaluate the efficacy of 5 and 10mg VESIcare® (solifenacin succinate) in patients with urgency who have overactive bladder syndrome.
Epistemonikos ID: 277f7279c374a32a0aed46c22bf537e646df9be9
First added on: May 04, 2024